| BHRB | PRESS-RELEASE | bullish | 7/10 | Burke & Herbert Financial Services Corp. completed its merger with LINKBANCORP, Inc. on May 1, 2026, combining the two b | May 1, 2026 |
| IRMD | PRESS-RELEASE | bullish | 7/10 | iRadimed reported Q1 2026 revenue of $22.0M (+13% YoY) and GAAP diluted EPS of $0.45 (+22% YoY), beating consensus estim | May 1, 2026 |
| GRO | PRESS-RELEASE | bearish | 6/10 | Brazil Potash Corp (GRO) announced a ~$55M public offering of 3.7M common shares and pre-funded warrants at $2.50/$2.499 | May 1, 2026 |
| IINN | PRESS-RELEASE | neutral | 4/10 | Inspira Technologies secured a $596,000 purchase order for its AME system from a leading Irish technological research un | May 1, 2026 |
| INUV | PRESS-RELEASE | neutral | 2/10 | Inuvo announced the nomination of advertising technology executive Sanja Partalo to its Board of Directors. The move add | May 1, 2026 |
| COHN | PRESS-RELEASE | neutral | 5/10 | Cohen & Company reported Q1 2026 revenue of $57.9M (up 101.6% YoY) and net income attributable to common shareholders of | May 1, 2026 |
| LBTYA | PRESS-RELEASE | neutral | 4/10 | Liberty Global reported Q1 2026 revenue of $1.27B, essentially in line with consensus, and swung to net income of $358M | May 1, 2026 |
| HCAT | PRESS-RELEASE | neutral | 1/10 | Health Catalyst, Inc. announced it will report its Q1 2026 results on May 11, 2026. | May 1, 2026 |
| VXRT | PRESS-RELEASE | bearish | 7/10 | Vaxart reported a significant Q4 2025 EPS miss of -$0.10 versus the $0.02 consensus, a 600% negative surprise. No revenu | May 1, 2026 |
| TONX | PRESS-RELEASE | neutral | 1/10 | TON Strategy Company announced it will host a conference call on May 12, 2026 to discuss its Q1 2026 results. | May 1, 2026 |
| AMTX | PRESS-RELEASE | neutral | 1/10 | Aemetis, Inc. announced it will report its Q1 2026 results on May 7, 2026. | May 1, 2026 |
| SGU | PRESS-RELEASE | neutral | 1/10 | Star Group, L.P. announced it will host a conference call on May 7, 2026 to discuss its fiscal Q2 2026 results. | May 1, 2026 |
| ANF | PRESS-RELEASE | neutral | 1/10 | Abercrombie & Fitch Management Co. announced it will report its Q1 2026 results on May 27, 2026. | May 1, 2026 |
| PHAT | PRESS-RELEASE | neutral | 1/10 | Phathom Pharmaceuticals announced its participation in the Digestive Disease Week (DDW) 2026 annual meeting, including a | May 1, 2026 |
| CURR | PRESS-RELEASE | mixed | 6/10 | Currenc Group reported FY2025 revenue of $37.8M (down 18.5% reported, 10.3% on a like-for-like basis), with gross margin | May 1, 2026 |
| KYN | PRESS-RELEASE | neutral | 2/10 | Kayne Anderson Energy Infrastructure Fund declared a monthly distribution of $0.085 per share for May 2026, payable on M | May 1, 2026 |
| IESC | PRESS-RELEASE | bullish | 6/10 | IES Holdings reported Q2 fiscal 2026 adjusted EPS of $4.16, above the $3.95 consensus, on revenue of $974M (vs. $1.01B c | May 1, 2026 |
| REKR | PRESS-RELEASE | neutral | 2/10 | Rekor Systems announced it will release Q1 2026 earnings on May 11, 2026, after market close, with a conference call at | May 1, 2026 |
| GIL | PRESS-RELEASE | neutral | 2/10 | Gildan Activewear released the voting results from its annual meeting, with all nine director nominees elected, auditor | May 1, 2026 |
| IFRX | PRESS-RELEASE | neutral | 1/10 | InflaRx N.V. announced it will report its Q1 2026 results on May 7, 2026. | May 1, 2026 |
| SYBT | PRESS-RELEASE | neutral | 4/10 | Stock Yards Bancorp completed its acquisition of Field & Main Bancorp, expanding its footprint in Kentucky and Indiana w | May 1, 2026 |
| CSHR | PRESS-RELEASE | neutral | 5/10 | CoinShares reported FY2025 revenue of $165.7M (+6.5% YoY) and Segment EBITDA of $131.3M (+5.4% YoY), with Asset Manageme | May 1, 2026 |
| AXSM | PRESS-RELEASE | bullish | 8/10 | Axsome Therapeutics announced FDA approval of AUVELITY for agitation associated with Alzheimer's disease dementia, a maj | May 1, 2026 |
| SACH | PRESS-RELEASE | neutral | 1/10 | Sachem Capital Corp. announced it will report its Q1 2026 results. | May 1, 2026 |
| ESPR | PRESS-RELEASE | bullish | 7/10 | Esperion has agreed to be acquired by ARCHIMED for $3.16 per share in cash at closing, plus contingent milestone payment | May 1, 2026 |
| MPLT | PRESS-RELEASE | neutral | 4/10 | MapLight Therapeutics announced completion of enrollment in the Phase 2 ZEPHYR trial for ML-007C-MA in schizophrenia (30 | May 1, 2026 |
| MOLN | PRESS-RELEASE | neutral | 4/10 | Molecular Partners announced publication of Phase 1 data for MP0317, a tumor-localized CD40 agonist, in Nature Cancer. T | May 1, 2026 |
| PPHC | PRESS-RELEASE | neutral | 3/10 | PPHC announced that its subsidiary MultiState acquired the assets of Cowen Consulting and Putnam Strategies, hiring Lee | May 1, 2026 |
| SHEN | PRESS-RELEASE | bearish | 6/10 | Shenandoah Telecommunications reported Q1 2026 revenue of $92.2M (+4.8% YoY), slightly above consensus of $91.3M, but GA | May 1, 2026 |
| PWP | PRESS-RELEASE | bearish | 7/10 | PWP reported Q1 2026 revenue of $148.9M, down 30% YoY, with a GAAP operating loss of $12.9M and adjusted EPS of $0.05. T | May 1, 2026 |